Federal Grant Opportunities

82,290 opportunities from Grants.gov – 1,023 currently open for applications. Data from SAM.gov and Grants.gov, covering federal grant programs and opportunities across all 50 states; see our methodology.

Publisher	PlainGrants
Sources	the SAM.gov Assistance Listings and Grants.gov

Federal Grant Opportunities

All Opportunities

Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)

Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)

Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)

Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

NSF Scholarships in Science, Technology, Engineering, and Mathematics Program

NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)

Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional)

Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)

NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

FOUNDATIONS OF TRUSTED SYSTEMS

Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)

Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)

Alcohol Health Services Research (R34 Clinical Trial Optional)

Alcohol Health Services Research (R01 Clinical Trial Optional)

Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)

Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)

Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required)

Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required)

Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)

Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required)

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)

New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)

New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)

The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)

Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R01 Clinical Trial Required)

Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R34 Clinical Trial Required)

Occupational Safety and Health Training Project Grants (T03)

Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)

Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)

Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)

Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)

Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)